Vice President, Business Operations & Technology
Celina Chang is the vice president of business operations & technology at LabCentral. She provides direction and guidance to shared and private lab operations. She has worked for almost 20 years as a cell-culture scientist in several biotech companies, with her focus being tissue engineering. Prior to joining LabCentral, she spent close to two years as a senior scientist at InVivo Therapeutics, a company developing groundbreaking technologies for the treatment of spinal cord injuries (SCI) and more than six years at Pervasis Therapeutics, a company advancing new therapies to improve dramatically the outcomes of common vascular interventions. She joined the company while it was still an early-stage biotech and was instrumental in advancing several of its products through clinical trials. Pervasis was acquired by Shire. Celina earned her bachelor’s degree in bioengineering from Cornell University.
Favorite school science project: “I had a hard time thinking that far back! I do remember making a Lego house and wiring it up to have functioning lights in the all the rooms…”